Eisai
4523.T
#2079
Rank
HK$73.93 B
Marketcap
HK$261.97
Share price
6.09%
Change (1 day)
14.62%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2026 (TTM): HK$2.96 Billion

According to Eisai's latest financial reports the company's current earnings are HK$5.44 Billion. In 2025 the company made an earning of HK$3.34 Billion a decrease over its 2024 earnings that were of HK$4.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$2.96 B-11.54%
2025 HK$3.34 B-20.48%
2024 HK$4.21 B2.42%
2023 HK$4.11 B-2404.04%
2022 -HK$0.18 Billion-103.6%
2021 HK$4.96 B-39.81%
2020 HK$8.24 B7.44%
2019 HK$7.67 B17.22%
2018 HK$6.54 B86.16%
2017 HK$3.51 B-23.52%
2016 HK$4.59 B26.97%
2015 HK$3.62 B22.3%
2014 HK$2.96 B-46.07%
2013 HK$5.49 B-21.85%
2012 HK$7.02 B-20.59%
2011 HK$8.84 B-8.91%
2010 HK$9.71 B19.21%
2009 HK$8.14 B